BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vahabi M, Blandino G, Di Agostino S. MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies. Transl Cancer Res 2021;10:3090-110. [PMID: 35116619 DOI: 10.21037/tcr-20-2530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu L, Li M, Tang G, Shi L, Liu W. Role of salivary miRNAs as noninvasive biomarkers in head and neck squamous cell carcinomas and oral potentially malignant disorders – Reply. Oral Oncology 2022;135:106224. [DOI: 10.1016/j.oraloncology.2022.106224] [Reference Citation Analysis]
2 Kim H, Eun S, Jeong WJ, Ahn SH, Bae YJ, Lee JS, Kim H. Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma. Sci Rep 2022;12:13383. [PMID: 35927424 DOI: 10.1038/s41598-022-17740-9] [Reference Citation Analysis]
3 Rocca V, Blandino G, D’antona L, Iuliano R, Di Agostino S. Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment. Cancers 2022;14:3664. [DOI: 10.3390/cancers14153664] [Reference Citation Analysis]
4 Barber PR, Flores-borja F, Alfano G, Ng K, Weitsman G, Dolcetti L, Mustapha R, Wong F, Vicencio JM, Galazi M, Opzoomer JW, Arnold JN, Kordasti S, Doyle J, Greenberg J, Dillon MT, Harrington KJ, Forster MD, Coolen ACC, Ng T. Predicting Progression Free Survival after Systemic Therapy in Advanced Head and Neck Cancer: Bayesian regression and Model development.. [DOI: 10.1101/2021.09.22.21263942] [Reference Citation Analysis]